ARCHIVES

Unclear Whether Clinical Trials Benefit Patients, Review Finds

This article is from The Cancer Letter archive.

Vol. 27 No. 2 | February 27, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: Breast Cancer Coalition Seeks Survivors, Activists For 3-Day Course In Advocacy

April 28, 1995

NEW OIG Awards Bring Total to 58

November 13, 1987

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

January 17, 1992

Biomed Research Absent from Bush State of the Union.

January 26, 2007

ASCO, AACR Call NCI Bypass Budget A Key Advocacy Tool, Seek Larger Role In Writing It.

July 14, 2000

FDA orders “limited distribution” for lung cancer drug Iressa.

June 24, 2005